Clinical Trial Update: Safety and Efficacy Study of ABT-089 in Adults With Mild to Moderate Alzheimer's Disease [Phase 2]

View source ↗

Summary

A Phase 2 safety and efficacy trial of ABT-089 in adults with mild to moderate Alzheimer's disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• ABT-089

Snippet

Sponsor: Abbott | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED